424 related articles for article (PubMed ID: 30816645)
1. 2018 APLAR axial spondyloarthritis treatment recommendations.
Tam LS; Wei JC; Aggarwal A; Baek HJ; Cheung PP; Chiowchanwisawakit P; Dans L; Gu J; Hagino N; Kishimoto M; Reyes HM; Soroosh S; Stebbings S; Whittle S; Yeap SS; Lau CS
Int J Rheum Dis; 2019 Mar; 22(3):340-356. PubMed ID: 30816645
[TBL] [Abstract][Full Text] [Related]
2. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis.
Wendling D; Lukas C; Prati C; Claudepierre P; Gossec L; Goupille P; Hudry C; Miceli-Richard C; Molto A; Pham T; Saraux A; Dougados M
Joint Bone Spine; 2018 May; 85(3):275-284. PubMed ID: 29407043
[TBL] [Abstract][Full Text] [Related]
3. Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.
Wei JC; Liu CH; Tseng JC; Hsieh LF; Chen CH; Chen HH; Chen HA; Chen YC; Chou CT; Liao HT; Lin YC; Luo SF; Yang DH; Yeo KJ; Tsai WC;
Int J Rheum Dis; 2020 Jan; 23(1):7-23. PubMed ID: 31777200
[TBL] [Abstract][Full Text] [Related]
4. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; van den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
Arthritis Rheumatol; 2016 Feb; 68(2):282-98. PubMed ID: 26401991
[TBL] [Abstract][Full Text] [Related]
5. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.
Lau CS; Chia F; Dans L; Harrison A; Hsieh TY; Jain R; Jung SM; Kishimoto M; Kumar A; Leong KP; Li Z; Lichauco JJ; Louthrenoo W; Luo SF; Mu R; Nash P; Ng CT; Suryana B; Wijaya LK; Yeap SS
Int J Rheum Dis; 2019 Mar; 22(3):357-375. PubMed ID: 30809944
[TBL] [Abstract][Full Text] [Related]
6. Update on recommendations for eligibility of government subsidization of biologic disease-modifying antirheumatic drugs for the treatment of axial spondyloarthritis in Singapore.
Phang KF; Lahiri M; Fong WWS; Leong KH; Leung YY; Lim AYN; Lui NL; Manghani M; Tan TC; Santosa A; Sriranganathan MK; Suresh E; Teng GG; Cheung PP
Int J Rheum Dis; 2020 Feb; 23(2):165-173. PubMed ID: 31762225
[TBL] [Abstract][Full Text] [Related]
7. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
van der Heijde D; Ramiro S; Landewé R; Baraliakos X; Van den Bosch F; Sepriano A; Regel A; Ciurea A; Dagfinrud H; Dougados M; van Gaalen F; Géher P; van der Horst-Bruinsma I; Inman RD; Jongkees M; Kiltz U; Kvien TK; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compàn V; Ozgocmen S; Pimentel-Santos FM; Reveille J; Rudwaleit M; Sieper J; Sampaio-Barros P; Wiek D; Braun J
Ann Rheum Dis; 2017 Jun; 76(6):978-991. PubMed ID: 28087505
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNFs in axial spondyloarthritis.
Kocijan R; Muschitz C; Rech J
Wien Med Wochenschr; 2015 Jan; 165(1-2):10-3. PubMed ID: 25572548
[TBL] [Abstract][Full Text] [Related]
9. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations.
Rohekar S; Chan J; Tse SM; Haroon N; Chandran V; Bessette L; Mosher D; Flanagan C; Keen KJ; Adams K; Mallinson M; Thorne C; Rahman P; Gladman DD; Inman RD
J Rheumatol; 2015 Apr; 42(4):665-81. PubMed ID: 25684768
[TBL] [Abstract][Full Text] [Related]
10. The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.
Spadaro A; Lubrano E; Marchesoni A; Cauli A; Cantini F; Carotti M; D'Angelo S; Grassi W; Lapadula G; Macchioni P; Mathieu A; Punzi L; Ramonda R; Salaffi F; Salvarani C; Scarpa R; Olivieri I
Clin Exp Rheumatol; 2014; 32(4):465-70. PubMed ID: 24850468
[TBL] [Abstract][Full Text] [Related]
11. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.
Bautista-Molano W; Fernández-Ávila DG; Brance ML; Ávila Pedretti MG; Burgos-Vargas R; Corbacho I; Cosentino VL; Díaz Coto JF; Giraldo Ho E; Gomes Resende G; Gutiérrez LA; Gutiérrez M; Ibáñez Vodnizza SE; Jáuregui E; Ocampo V; Palleiro Rivero DR; Palominos PE; Pacheco Tena C; Quiceno GA; Saldarriaga-Rivera LM; Sommerfleck FA; Goecke Sariego A; Vera Barrezueta C; Vega Espinoza LE; Vega Hinojosa O; Citera G; Lozada C; Sampaio-Barros PD; Schneeberger E; Soriano ER
Nat Rev Rheumatol; 2023 Nov; 19(11):724-737. PubMed ID: 37803079
[TBL] [Abstract][Full Text] [Related]
12. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.
Smolen JS; Braun J; Dougados M; Emery P; Fitzgerald O; Helliwell P; Kavanaugh A; Kvien TK; Landewé R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; Wit Md; Baraliakos X; Betteridge N; Burgos-Vargas R; Collantes-Estevez E; Deodhar A; Elewaut D; Gossec L; Jongkees M; Maccarone M; Redlich K; van den Bosch F; Wei JC; Winthrop K; van der Heijde D
Ann Rheum Dis; 2014 Jan; 73(1):6-16. PubMed ID: 23749611
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
14. Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Wang S; He Q; Shuai Z
Clin Rheumatol; 2018 Feb; 37(2):439-450. PubMed ID: 29290076
[TBL] [Abstract][Full Text] [Related]
15. Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis.
da Cruz Lage R; Marques CDL; Oliveira TL; Resende GG; Kohem CL; Saad CG; Ximenes AC; Gonçalves CR; Bianchi WA; de Souza Meirelles E; Keiserman MW; Chiereghin A; Campanholo CB; Lyrio AM; Schainberg CG; Pieruccetti LB; Yazbek MA; Palominos PE; Goncalves RSG; Assad RL; Bonfiglioli R; Lima SMAAL; Carneiro S; Azevedo VF; Albuquerque CP; Bernardo WM; Sampaio-Barros PD; de Medeiros Pinheiro M
Adv Rheumatol; 2021 Jan; 61(1):4. PubMed ID: 33468245
[TBL] [Abstract][Full Text] [Related]
16. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S; Nikiphorou E; Sepriano A; Ortolan A; Webers C; Baraliakos X; Landewé RBM; Van den Bosch FE; Boteva B; Bremander A; Carron P; Ciurea A; van Gaalen FA; Géher P; Gensler L; Hermann J; de Hooge M; Husakova M; Kiltz U; López-Medina C; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Nissen MJ; Pimentel-Santos FM; Poddubnyy D; Proft F; Rudwaleit M; Telkman M; Zhao SS; Ziade N; van der Heijde D
Ann Rheum Dis; 2023 Jan; 82(1):19-34. PubMed ID: 36270658
[TBL] [Abstract][Full Text] [Related]
17. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].
Braun J; Zochling J; Märker-Hermann E; Stucki G; Böhm H; Rudwaleit M; Zeidler H; Sieper J
Z Rheumatol; 2006 Dec; 65(8):728-42. PubMed ID: 17119900
[TBL] [Abstract][Full Text] [Related]
19. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
[TBL] [Abstract][Full Text] [Related]
20. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
